Insider Stock Trading History of Dubinett Howard


The following table details the trading activities (stock purchases, stock sales, and stock option exercises) reported to the Securities and Exchange Commission (SEC) by insider Dubinett Howard since year 2005. The trader's CIK number is 1189454. At the time of this reporting, Dubinett Howard is the Executive VP, COO of Bio Reference Laboratories Inc . (stock ticker symbol BRLI). See this page for all insider trading activities at Bio Reference Laboratories Inc .


Stock purchases, sales, and option exercises reported by insider Dubinett Howard since 2005.
  Trade Date   Symbol Company Name (Issuer) Trade Type     Shares       Price ($)   Value ($)
2013-09-13 BRLI Bio Reference Laboratories Inc Sale 20,000 29.40 588,020
2012-12-18 BRLI Bio Reference Laboratories Inc Sale 10,000 29.66 296,620
2011-12-12 BRLI Bio Reference Laboratories Inc Buy 10,000 14.24 142,400
2011-04-26 BRLI Bio Reference Laboratories Inc Sale 432 23.75 10,260
2011-04-27 BRLI Bio Reference Laboratories Inc Sale 9,268 23.75 220,115
2011-04-21 BRLI Bio Reference Laboratories Inc Sale 300 23.78 7,134
2011-01-14 BRLI Bio Reference Laboratories Inc Sale 10,000 23.72 237,200
2010-10-15 BRLI Bio Reference Laboratories Inc Sale 10,000 21.48 214,800
2010-09-27 BRLI Bio Reference Laboratories Inc Sale 10,000 21.00 210,000
2010-06-11 BRLI Bio Reference Laboratories Inc Sale 10,000 23.05 230,460
2010-06-14 BRLI Bio Reference Laboratories Inc Sale 15,000 23.43 351,510
2010-03-11 BRLI Bio Reference Laboratories Inc Sale 10,000 44.97 449,700
2009-10-19 BRLI Bio Reference Laboratories Inc Sale 85,803 29.98 2,572,373
2007-09-28 BRLI Bio Reference Laboratories Inc Sale 79,644 17.26 1,374,655
2006-03-30 BRLI Bio Reference Laboratories Inc Sale 90,485 14.34 1,297,554

Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Dubinett Howard (Executive VP, COO of Bio Reference Laboratories Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.